参考文献/References:
[1] England JD,Neuropathy AP. Peripheral neuropathy[J].Lancet,2004,363(9427):2151-2161.
[2] Ross MA.Electrodiagnosis of peripheral neuropathy[J].Neurol Clin,2012,30(2):529-549.
[3] Overell JR.Peripheral neuropathy: pattern recognition for the pragmatist[J].Pract Neurol,2011,11(2):62-70.
[4] Huan MC,Bromberg M.Advances in the laboratory evaluation of peripheral neuropathies[J].Curr Neurol Neurosci Rep,2012,12(1):84-91.
[5] Schwartz SR,Jones SL,Getchius TS,et al.Reconciling the clinical practice guidelines on Bell’s palsy from the AAO-HNSF and the AAN[J].Otolaryngol Head Neck Surg,2014,150(5):709-711.
[6] Gronseth GS,Paduga R.American academy of neurology[J].Evidence-based guideline update:steroids and antivirals for Bell palsy:report of the Guideline Development Subcommittee of the American Academy of Neurology.Neurology,2012,79(22):2209-2213.
[7] Baugh RF,Basura GJ,Ishii LE,et al.Clinical practice guideline: Bell’s Palsy executive summary[J].Otolaryngol Head Neck Surg,2013,149(5):656-663.
[8] Zakrzewska JM,Linskey ME.Trigeminal neuralgia[J].BMJ,2015,350:h1238.
[9] Deyo RA,Weinstein JN.Clinical practice Low back pain[J].N Engl J Med,2001,344(5):363-370.
[10] Ropper AH,Zafonte RD.Clinical practice.Sciatica[J].N Engl J Med,2015,372(13):1240-1248.
[11] Van Alfen N.Clinical and pathophysiological concepts of neuralgic amyotrophy[J].Nat Rev Neurol,2011,7(6):315-322.
[12] Katz JN,Simmons BP.Clinical practice.Carpal tunnel syndrome[J].New Engl J Med,2002,346(23):1807-1812.
[13] Atroshi IM,Hofer M.Methylprednisolone injections for the CTS:A randomized,placebo-controlled trial[J].Ann Intern Med,2013,159(5):309-317.
[14] Andreu JL,Ly-Pen D,Millán I,et al.Local injection versus surgery in carpal tunnel syndrome: neurophysiologic outcomes of a randomized clinical trial[J].Clin Neurophysiol,2014,125(7):1479-1484.
[15] Middleton SD,Anakwe RE.Carpal tunnel syndrome[J].BMJ,2014,349:g6437.
[16] Caliandro P,La Torre G,Padua R,et al.Treatment for ulnar neuropathy at the elbow[J].Cochrane Database Syst Rev,2012,7:CD006839.
[17] Carter GT,Weiss MD,Friedman AS,et al.Diagnosis and treatment of work-related ulnar neuropathy at the elbow[J].Phys Med Rehabil Clin N Am,2015,26(3):513-522.
[18] 卢袓能,王真真,关景霞.神经疾病临床症候学(英汉双语版)[M].北京:人民军医出版社,2015:855-856.
[19] Pomeroy G,Wilton J,Anthony S.Entrapment neuropathy about the foot and ankle: an update[J].J Am Acad Orthop Surg,2015,23(1):58-66.
[20]Bourque PR,Chardon JW,Massie R.Autoimmune peripheral neuropathies[J].Clin Chim Acta,2015,449:37-42.
[21] Patwa HS,Chaudhry V,Katzberg H,et al.Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J].Neurology,2012,78(13):1009-1015.
[22] Van Den Berg B,Walgaard C,Drenthen J,et al.Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis[J].Nat Rev Neurol,2014,10(8):469-482.
[23] Hughes RA,Bouche P,Cornblath DR,et al.European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society[J].Eur J Neurol,2006,13(4):326-332.
[24] Diagnosis LN,Treatment of chronic acquired demyelinating polyneuropathies[J].Nat Rev neurol,2014,10(8):435-446.
[25] Rajabally YA.Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy[J].Muscle Nerve,2015,51(5):657-661.
[26] Kleyman I,Brannagan TH.Treatment of chronic inflammatory demyelinating polyneuropathy[J].Curr Neurol Neurosci Rep,2015,15(7):47.
[27] European Federation of Neurological Societies,Peripheral Nerve Society,Van Schaik IN,et al.European federation of neurological societies/peripheral nerve society guideline on management of multifocal motor neuropathy[J].Eur J Neurol,2006,13(8):802-808.
[28] Vlam L,Van Der Pol WL,Cats EA,et al.Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies[J].Nat Rev Neurol,2012,8(1):48-58.
[29] Gwathmey KG,Burns TM,Collins MP,et al.Vasculitic neuropathies[J].Lancet Neurol,2014,13(1):67-82.
[30] Blase F.Diagnosis and therapeutic options for peripheral vasculitic neuropathy[J].Ther Adv musculoskelet Dis,2015,7(2):45-55.
[31] Vallat JM,Mathis S,Ghorab K,et al.Natalizumab as a Disease-modifying therapy in chronic inflammatory demyelinating polyneuropathy-A report of three cases[J].Eur Neurol,2015,73(5/6):294-302.
[32] Piepers S,Van Den Berg-Vos R,Van Der Pol WL,et al.Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial[J].Brain,2007,130(Pt 8):2004-2010.
[33] Karam C,Klein CJ,Dispenzieri A,et al.Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome[J].Neurology,2015,84(19):1981-1987.
[34] Callaghan BC,Cheng HT,Stables CL,et al.Diabetic neuropathy: clinical manifestations and current treatments[J].Lancet Neurol,2012,11(6):521-534.
[35] Griebeler ML,Morey-Vargas OL,Brito JP,et al.Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis[J].Ann Intern Med,2014,161(9):639-649.
[36] Javed S,Petropoulos IN,Alam U,et al.Treatment of painful diabetic neuropathy[J].Ther Adv Chronic Dis,2015,6(1):15-28.
[37] Gibbons CH,Freeman R.Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes[J].Brain,2015,138(Pt 1):43-52.
[38] Latronico N,Bolton CF.Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis[J].Lancet Neurol,2011,10(10):931-941.
[39] Coriat R,Alexandre J,Nicco C,et al.Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir[J].J Clin Invest,2014,124(1):262-272.
-----------------------------------------------
[40] Stabler SP.Clinical practice.Vitamin B12 deficiency[J].N Engl J Med,2013,368(2):149-160.
[41] Reilly MM,Shy ME.New treatments in genetic neuropathies[J].J Neurol Neurosurg Psychiatry,2009,80(12):1304-1314.
[42] Rossor AM,Evans MR,Reilly MM.A practical approach to the genetic neuropathies[J].Pract Neurol,2015,15(3):187-198.
[43] Baron R,Binder A,Wasner G.Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment[J].Lancet Neurol,2010,9(8):807-819.
[44] Attal N,Cruccu G,Baron R,et al.European Federation of Neurological Societies[J].EFNS guidelines on the pharmacological treatment of neuropathic pain:2010 revision.Eur J Neurol,2010,17(9):1e88-1113.
[45] Itoh T,Pleasure D.The future of research in neuropathy[J].JAMA Neurol,2015,72(1):5-7.